Past Conference

WORLD CANCER CONGRESS-2017

The World Congress on Cancer Research & Therapy was held between October 02-03, 2017 at the
San Diego, California, USA. The Conference witnessed the participation of over 100 participants representing more than 30 countries across the world. The countries include: USA, UK, Germany, Poland, Canada, Japan, Columbia, Brazil, Austria, Latvia, Taiwan, Malaysia, India, Iran, South Korea, Indonesia, Israel, UAE, Saudi Arabia, Oman etc.

With a focus on the Core research of the cancer, the theme of the WCC-2017, San Diego was “Aspiration, inspiration and imagination – Cancer research, Treatment and Care””. The conference addressed a variety of topics relevant to the main theme, including specific questions about the research system at large, such as research assessment, funding, metrics, and indicators of research output.

With the huge support from our Chair and Co-chairs conference witnessed the huge success. Our Conference Chairs are as follows.

  1. Paul B. Fisher, Virginia Commonwealth University, USA
  2. LuZhe Sun, University of Texas Health Science Center, San Antonio, USA
  3. Paul J. Davis, Albany College of Pharmacy and Health Sciences, USA
  4. Bimal Ray, University of Missouri, Columbia, USA
  5. Xinhua Ji, National Cancer Institute, USA
  6. Ali S. Arbab, Augusta University, USA
  7. Durwood B. Ray, Grove City College, USA
  8. Harry Gould, LSU Health Sciences Center, New Orleans, USA

And the Key Note talks Delivered by the top most eminent fellows at their respective field of research.

Key Note Forum:

Paul B. Fisher, Virginia Commonwealth University, USA

Croce, Carlo M, Ohio State University, USA

Paul J. Davis, Albany College of Pharmacy and Health Sciences, USA

Michael Karin, UC San Diego, USA

 With respect to plenary Talks, over 70 attended the meeting. According to the conference records, the distribution of WCC registrants and attendees was as follows

Paul B. Fisher, Virginia Commonwealth University, USA

Croce, Carlo M, Ohio State University, USA

Paul J. Davis, Albany College of Pharmacy and Health Sciences, USA

Michael Karin, UC San Diego, USA

LuZhe Sun, University of Texas Health Science Center, San Antonio, USA

Bimal Ray, University of Missouri, Columbia, USA

Richard Kremer, McGill University, Canada

Feng Wang-Johanning, SRI International, California, USA

Antonino B. D'Assoro, Mayo Clinic School of Medicine, USA

Jun Cai, Cardiff University, UK

Ko Sato, St. Marianna University, Japan

Jerome Check, Cooper Medical School of Rowan University, USA

Roger Su, ENT Associates of South Atlanta, Georgia, USA

James Kim, University of Texas Southwestern Medical Center, USA

Pavel Vodicka, Charles University, Czech Republic

Michael J. Powell, DiaCarta, Inc., USA

Tesshi Yamada, National Cancer Center Research Institute, Japan

Veronika Vymetalkova, Charles University, Czech Republic

Priyanka Jha, University of California, San Francisco, USA

Rafael A. Guerrero, National University of Colombia, Colombia

Chaosheng Deng, First Affiliated Hospital of Fujian Medical University, China

Durwood B. Ray, Grove City College, USA

Xinhua Ji, National Cancer Institute, USA

Yong Jia, Genomics Institute of the Novartis Research Foundation, USA

Kunnimalaiyaan, Medical College of Wisconsin, USA

Huizi Sha, The Comprehensive Cancer Center of Drum-Tower Hospital, China

Aslam A Khan, University of Missouri, Columbia, USA

Diana Vanessa Suárez Ayala, Hospital Infantil Los Ángeles, Colombia

Harry Gould, LSU Health Sciences Center, New Orleans, USA

Stephen G Maher, Trinity College Dublin, Ireland

Ali S. Arbab, Augusta University, USA

Besarion Partsva, Tbilisi State Medical University, Georgia

Martin Oft, ARMO BioSciences, USA

Arthur Paredes Gatti, Federal University, Brazil

Ni Ying, Jiangsu University, China

Julianti, Jenderal Soedirman University, Indonesia

Ammar Aleter, Hamad Medical Corporation(HMC), Qatar

Maria Inês Rebelo Gonçalves, Federal University of São Paulo, Brazil

Kamel Farag, King Faisal Special Hospital & Research Centre (Jeddah), Saudi Arabia

Tuyen Vu, Dendreon, USA

 

 

 EUROPEAN CANCER SUMMIT-2017

The European Cancer Summit 2017 was held between September 04-05, 2017 at the Rome, Italy. The Conference witnessed the participation of over 70 participants representing more than 30 countries across the world. The countries include: USA, UK, Germany, Poland, Canada, Japan, Columbia, Brazil, Austria, Latvia, Taiwan, Malaysia, India, Iran, China, South Korea, Indonesia, Israel, UAE, Saudi Arabia, Oman etc.

With a focus on the Core research of the cancer, the theme of the ESC-2017, Rome was “Novel Discoveries in Cancer Research & Treatment”. The conference addressed a variety of topics relevant to the main theme, including specific questions about the research system at large, such as research assessment, funding, metrics, and indicators of research output.

With the huge support from our Chair and Co-chairs conference witnessed the huge success. Our Conference Chairs are as follows.

  1. Paul B. Fisher, Virginia Commonwealth University, USA
  2. Patrizio Giacomini, Regina Elena National Cancer Istitute, Italy
  3. David S. Wishart, University of Alberta, Canada
  4. KENNETH Marcu, Stony Brook University, USA
  5. Sevtap Savas, Memorial University of Newfoundland, Canada
  6. Charles Lin, National Cancer Institute, USA

And the Key Note talks Delivered by the top most eminent fellows at their respective field of research.

Key Note Forum:

Paul B. Fisher, Virginia Commonwealth University, USA

Joyce Schroeder, University of Arizona, USA

With respect to plenary Talks, over 50 attended the meeting. According to the conference records, the distribution of WCC registrants and attendees was as follows

Paul B. Fisher, Virginia Commonwealth University, USA

Joyce Schroeder, University of Arizona, USA

Tieli Wang, California State University, USA

Touati Benoukraf, Cancer Science Institute of Singapore, National University of Singapore, Singapore

Xiaolong Yang, Queen’s University, Canada

Sevtap Savas, Memorial University of Newfoundland, Canada

David S. Wishart, University of Alberta, Canada

Behrouz Kherad, Universitätsmedizin Berlin, Germany

KENNETH Marcu, Stony Brook University, USA

Marianna Penzo,Università di Bologna, Italy

Patrizio Giacomini, Regina Elena National Cancer Istitute, Italy

Tatjana Abaffy, Duke University, USA

Eli Bar, Case Western Reserve University and The Case Comprehensive Cancer Center, USA

Jenny Y. Wang, Faculty of Medicine, University of New South Wales, Sydney, Australia

Gurmit Singh, McMaster University, Canada

Manijeh Pasdar, University of Alberta, Canada

El Tannouri Rachelle, University of Lorraine, France

Andrea De Vito, Morgagni-Pierantoni Hospital, Italy

Massimo Nabissi, University of Camerino, Italy

Dexian Zheng, Peking Union Medical College & Obio Technology Corp. Ltd., China

James K Fortson, Atlanta Cancer Research and Education Foundation, USA

Charles Lin, National Cancer Institute, USA

Uri Nir, Bar Ilan University, Israel

Jian Gu, The University of Texas MD Anderson Cancer Center, USA

Zheng-Rong Lu, Case Western Reserve University, USA

Antonino Baez, Autonomous University of Puebla, Mexico

Marta Kijanka, Vice President of R&D at APO-T B.V, The Netherlands

Maria Grazia Spurio, Director of educational and psychological center "Genius Academy", Italy

Ji-Bin Li, Sun Yat-sen University Cancer Center, China

Hamid Reza Dehghan Manshadi, Iran University of Medical Sciences, Iran

Adone Mohd-Sarip, Queen's University Belfast, UK

Francesca Duraturo, Federico II University School of Medicine, Italy

Francesca Orso , University of Torino, Italy

Ashish Chaurasia, Government Medical College, Thiruvananthapuram, India

Sachio Fushida, Kanazawa University Graduate School of Medical Sciences, Japan

Fatemeh Nabavizadeh, Tehran University of Medical Sciences, Iran

 

Stay Tuned for upcoming 4th World Congress on Cancer Research & Therapy (WCC-2018) during August 13-15, 2018 in Rome, Italy….

 

Copyrights © 2016-17 Innovinc Pvt Ltd All Rights Reserved